Understanding Determinants of Patient Preferences Between Stool Tests and Colonoscopy for the Assessment of Disease Activity in Inflammatory Bowel Disease
Author(s) -
Maria Barsky,
Joseph Meserve,
Helen Le,
Angelina Collins,
Siddharth Singh,
Brigid S. Boland,
William J. Sandborn,
Parambir S. Dulai
Publication year - 2020
Publication title -
digestive diseases and sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.14
H-Index - 124
eISSN - 1573-2568
pISSN - 0163-2116
DOI - 10.1007/s10620-020-06568-w
Subject(s) - colonoscopy , medicine , inflammatory bowel disease , hepatology , disease , gastroenterology , test (biology) , colorectal cancer , paleontology , cancer , biology
Evidence is now available in support of using fecal biomarkers to monitor disease activity in inflammatory bowel disease (IBD). Patient adherence is often cited as a barrier to implementation. We assessed patient determinants for using stool tests to monitor disease activity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom